Hence, a better understanding of the molecular mechanisms that regulate NCC could lead to the development of drugs that target NCC regulation with fewer adverse effects and to a better understanding of and treatment for hypertension and disorders of extracellular fluid volume. This evidence concerns the gene SLC12A3 and hypertensive disorder.